Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Nissen SE. Zerlasiran for the Treatment of Atherosclerotic Cardiovascular Disease-Reply. JAMA 2025 Mar 27. doi: 10.1001/jama.2025.0034.
PMID: 40146122


Privacy Policy